Valvular Heart Disease Registry
Launched by TECHNICAL UNIVERSITY OF MUNICH · Apr 4, 2018
Trial Information
Current as of August 23, 2025
Recruiting
Keywords
ClinConnect Summary
The Valvular Heart Disease Registry is a clinical trial aimed at studying patients who have severe problems with their heart valves and are scheduled to undergo a special procedure called a transcatheter valvular intervention. This trial will collect important information about patients before, during, and after their treatment. By analyzing this data, researchers hope to learn more about how these procedures can help improve patient outcomes and address various challenges related to heart valve issues.
To be eligible for this study, participants should be between the ages of 65 and 74 and have a serious heart valve defect that requires intervention. It’s important to note that individuals must be able to give informed consent, meaning they understand the study and agree to participate. If you join this trial, you can expect to have your health monitored closely, and your experiences will contribute to a better understanding of how to treat heart valve diseases effectively. This research is crucial as it may lead to improved care for many patients with similar conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Severe valvular defect planned for valvular intervention
- Exclusion Criteria:
- • - No informed consent
About Technical University Of Munich
The Technical University of Munich (TUM) is a leading research institution in Germany, renowned for its commitment to excellence in education, innovation, and technology transfer. With a strong emphasis on interdisciplinary collaboration, TUM fosters advancements in various fields, including medicine and life sciences. The university actively engages in clinical research, aiming to translate scientific discoveries into practical applications that improve patient outcomes. Through its state-of-the-art facilities and a network of partnerships with hospitals and industry, TUM is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and contribute significantly to the advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
München, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials